Pilot Study of Biomarkers for Radiation Therapy
Investigating Proteomic Biomarkers of Radiation Therapy Outcome: A Pilot Study
Sponsor: Benaroya Research Institute
Suspended
On hold: pending grant funding for further enrollment
Listed as NCT01050725, this observational or N/A phase trial focuses on Cancer and remains suspended. Sponsored by Benaroya Research Institute, it has been updated 11 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Suspended
-
Jul 2024 — Sep 2024 [monthly]
Suspended
-
May 2022 — Jul 2024 [monthly]
Suspended
-
Dec 2021 — May 2022 [monthly]
Suspended
-
Jan 2021 — Dec 2021 [monthly]
Suspended
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Suspended
-
Jun 2018 — Nov 2020 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
-
Jan 2017 — Aug 2017 [monthly]
Suspended NA
First recorded
Nov 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Benaroya Research Institute
- Fred Hutchinson Cancer Center
- Virginia Mason Hospital/Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .